The Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
The Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Ophthalmology, University of Heidelberg, Heidelberg, Baden-Wuerttemberg, Germany.
Ophthalmology. 2022 Aug;129(8):912-922. doi: 10.1016/j.ophtha.2022.04.005. Epub 2022 Apr 8.
To assess risk factors for lack of vision improvement after endothelial keratoplasty (EK).
Retrospective cohort study.
Patients aged 18 years and older in the Intelligent Research in Sight (IRIS®) Registry who underwent EK surgery in the United States between 2013 and 2018.
Change in visual acuity (VA) relative to baseline were determined at 6 months and 1 year. A multivariable population-average marginal model estimated using generalized estimating equations adjusting for sociodemographic factors, baseline vision, surgical indication, ocular comorbidities, and postoperative complications was used to identify factors associated with worse VA outcomes.
Visual acuity and lack of VA improvement at 1 year compared with preoperative status.
A total of 30 600 EK procedures (N = 25 666 unique patients) were included in the analysis. Overall, VA improved from median logarithm of the minimum angle of resolution (logMAR) 0.54 (Snellen 20/69) (interquartile range [IQR] ± 0.70) preoperatively to median logMAR 0.40 (20/50) (IQR ± 0.36) at 6 months and median logMAR 0.30 (20/40) (IQR ± 0.36) at 1 year postoperatively. A total of 30.3% of the overall cohort, 29.8% of Fuchs' endothelial corneal dystrophy (FECD) subgroup, and 27.4% of the bullous keratopathy (BK) subgroup did not show visual improvement at 1 year postoperatively. In the FECD subgroup, older age (risk ratio [RR], 1.05 per 5-year increase, 95% confidence interval [CI], 1.03-1.07) and female sex (RR, 1.10, 95% CI, 1.04-1.16) were associated with VA worse than or equal to baseline at 1 year postoperatively. In both FECD and BK subgroups, eyes with higher baseline logMAR VA (per 0.1 unit increase in logMAR) were more likely to have visual improvement postoperatively (FECD: RR, 0.82, 95% CI, 0.81-0.84; BK: RR, 0.91, 95% CI, 0.91-0.92), whereas postoperative rebubbling (FECD: RR, 1.10, 95% CI, 1.02-1.19; BK: RR, 1.31, 95% CI, 1.17-1.48) and repeat keratoplasties (FECD: RR, 1.41, 95% CI, 1.32-1.52; BK: RR, 1.42, 95% CI, 1.28-1.57) were associated with higher risk of no VA improvement.
In this large national cohort, postoperative rebubblings and repeat keratoplasties were identified as independent factors associated with worse VA outcomes after EK for both FECD and BK subgroups. Older age and female gender were associated with worse VA outcomes after EK in the FECD subgroup.
评估内皮角膜移植(EK)术后视力改善不佳的风险因素。
回顾性队列研究。
在美国 2013 年至 2018 年间接受 EK 手术的年龄在 18 岁及以上的 Intelligent Research in Sight(IRIS®)注册患者。
使用广义估计方程调整社会人口统计学因素、基线视力、手术适应证、眼部合并症和术后并发症的人群平均边缘模型来评估术后 6 个月和 1 年时相对于基线的视力变化。
与术前状态相比,术后 1 年的视力和视力改善不足。
共纳入 30600 例 EK 手术(N=25666 例患者)进行分析。总体而言,术后视力从术前中位数对数最小角分辨率(logMAR)0.54(Snellen 20/69)(四分位距[IQR]±0.70)改善至术后 6 个月时中位数 logMAR 0.40(20/50)(IQR±0.36),术后 1 年时中位数 logMAR 0.30(20/40)(IQR±0.36)。在整个队列中,30.3%,Fuchs 内皮角膜营养不良(FECD)亚组中 29.8%,大疱性角膜病变(BK)亚组中 27.4%在术后 1 年时未显示视力改善。在 FECD 亚组中,年龄较大(风险比[RR],每增加 5 岁为 1.05,95%置信区间[CI],1.03-1.07)和女性(RR,1.10,95%CI,1.04-1.16)与术后 1 年时的视力与基线相当或更差相关。在 FECD 和 BK 亚组中,基线 logMAR 视力较高(logMAR 每增加 0.1 单位)的眼术后更有可能改善视力(FECD:RR,0.82,95%CI,0.81-0.84;BK:RR,0.91,95%CI,0.91-0.92),而术后再次气肿(FECD:RR,1.10,95%CI,1.02-1.19;BK:RR,1.31,95%CI,1.17-1.48)和重复角膜移植(FECD:RR,1.41,95%CI,1.32-1.52;BK:RR,1.42,95%CI,1.28-1.57)与视力改善不足的风险增加相关。
在这项大型全国性队列研究中,术后再次气肿和重复角膜移植被确定为 FECD 和 BK 亚组 EK 术后视力结果较差的独立相关因素。年龄较大和女性与 FECD 亚组的 EK 术后视力结果较差相关。